Dr. Imazio pointed out that the data from the CORP-2 trial should be available early next year, and the data should help resolve whether colchicine is effective in patients with multiple recurrences.
Investigators still do not know the exact mechanism of action of colchicine.
Dr. Pullen is a medical writer based in the Chicago area.
Reference